Lifetech Scientific Corporation (HKG: 1302), a China-based medical device company, has announced that it has received market approval from the National Medical Products Administration (NMPA) for its innovative peripheral thrombus suction catheter. This device is designed for the removal of thrombi from the peripheral arterial and venous vascular systems, offering a new treatment option for patients with vascular thrombotic diseases.
Product Application and Benefits
The newly approved product can be utilized for percutaneous mechanical thrombectomy (PMT), a procedure that removes deep vein thrombosis (DVT) through mechanical thrombectomy and/or catheter suction. By employing this technology, medical professionals can effectively open occluded veins and alleviate symptoms in the affected limb. This catheter is the first home-grown Over-The-Wire (OTW) double lumen peripheral thrombus suction catheter, marking a significant advancement in the field of vascular intervention.
Innovation and Market Potential
The approval of Lifetech Scientific Corporation’s peripheral thrombus suction catheter by the NMPA not only highlights the company’s commitment to innovation but also addresses a critical need in the medical device market. As the first domestically produced device of its kind, it has the potential to reduce reliance on imported products and contribute to the growth of the domestic medical device industry in China.- Flcube.com
